Cardio Infrared Secures Distribution Rights for Miracle Minerals Fulvic Acid


LAS VEGAS, Sept. 30, 2008 (GLOBE NEWSWIRE) -- Cardio Infrared Technologies, Inc. (Pink Sheets:CIRT) www.cardio-cor.com, a leading Health and Wellness technology and marketing company, announced today the completed negotiations for the acquisition of distribution rights and private labeling of Miracle Minerals Fulvic acid.

Wayne Bailey, President and CEO of Cardio Infrared Technologies, Inc., stated, "Cardio Infrared Technologies, Inc. has acquired the private label distribution rights for Miracle Minerals all natural Fulvic acid. Though virtually unknown to the layman, there is perhaps no substance more vital to life than the biologically derived compounds known as Fulvic Acid. As living microbes decompose humic material, these microbes create the most biologically complex organic compounds on earth. It is a power pack, which aids and supplies all cellular life functions. Fulvic Acids enter into all living processes within the plant and animal kingdoms. When necessary, they act as "free-radical" scavengers, supply vital electrolytes, enhance and transport nutrients, catalyze enzyme reactions, increase assimilation, stimulate metabolism, chelate and change inorganic minerals into organically complex minerals, solubilize, energize and transport major and trace elements to the site of need, and demonstrate amazing capacity for electrochemical balance. Fulvic acids are involved in indispensable biochemical reactions which influence all biological life forms, both plant and animal."

This is the first of many supplements and future products that will be added to the product line of Cardio Infrared Technologies, Inc. Fulvic acid will enhance the results of the Cardio-Cor and improve revenues directly to the bottom line of the company. The Fulvic Acid product will also be offered outside our normal H&W Exerbike owner distribution system. Sales for 2009 are expected to exceed $.5 million.

About Cardio Infrared Technologies, Inc.

Cardio Infrared Technologies, Inc. is a technology and marketing company, which is focused on developing the revolutionary and evolutionary process of combining exercise equipment with medical benefits that go far beyond the normal benefits of standard exercise equipment. Cardio Infrared Technologies, Inc. is committed to continue to market this equipment to the exercise and medical markets and to aggressively expand the market to every country around the world. The equipment has already been featured on Good Morning America and The View. Cardio Infrared Technologies, Inc. also has an aggressive growth plan that includes acquisitions and development of innovate new equipment and programs in the exercise and medical industries.

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words or phrases "would be," "would allow," "intends to'" "will likely result," "are expected to," "will continue," "anticipate," "expect," "estimate," "project," "indicate," "could," "potentially," "should," "believe," "considers," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties. These include the company's historic lack of profitability, end user customer acceptance and actual demand, which may differ significantly from expectations, the need for the company to manage its growth, the need to raise funds for operations and other risks within the regulation of the industry. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation, to update any forward-looking statements to reflect occurrences, developments, events or circumstances after the date of such statement.



            

Contact Data